ArticleBMJ open2025
Lived realities of symptom burden among haemodialysis patients: a phenomenological study from rural Pakistan.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe prevalence of chronic kidney disease (CKD) is increasing at an alarming rate worldwide, leading to a growing number of patients developing kidney failure and requiring haemodialysis (HD). HD prolongs life and improves health, but it imposes substantial physical, nutritional, psychological and financial demands on patients. Patients on HD often endure a high symptom burden, which significantly impairs their lives.
objectiveThe study aimed to explore and describe the lived experiences of patients residing in rural areas of Pakistan receiving HD.
designA transcendental phenomenology.
settingDialysis unit of a tertiary care hospital in Mirpur, AJK, Pakistan.
participantsTwenty village-based patients with CKD receiving HD were recruited through a purposive sampling technique. DATA COLLECTION AND ANALYSIS: The data were collected through unstructured, in-depth, face-to-face interviews using an interview guide, as well as observation and document analysis. Thematic analysis used a Colaizzi seven-step method to derive key themes from the data.
resultsFive major themes emerged after the data analysis, reflecting the complex symptom burden experienced by patients: (1) Physical manifestations and loss of independence due to persistent pain and fatigue, leading to increased dependency in daily activities. (2) Emotional and cognitive impact characterised by emotional distress, including anxiety, helplessness and cognitive disturbances such as poor concentration and mental fatigue. (3) Challenges with dietary management and lifestyle adaptation due to difficulties in adhering to dietary and fluid restrictions, further complicated by limited resources, lack of individualised guidance and cultural dietary practices. (4) Financial and logistical hardships, including out-of-pocket expenses, loss of income due to reduced work capacity and geographic barriers, significantly affecting treatment adherence and continuity of care. (5) Post-dialysis experiences and side effects. Patients expressed diverse experiences: some mentioned transient relief after HD, while others described ongoing side effects.
conclusionPatients with CKD on HD may face multiple symptoms that impact physical, emotional, cognitive, dietary, financial and social domains, which potentially contribute to reduced quality of life. Persistent symptoms and limited support highlight the need for holistic, patient-centred care strategies that address their physical, emotional, psychosocial and financial challenges, particularly in rural and underserved populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.